I wasn't the one who commented about the personalized drug approval process. I think that's an important issue. I don't have an answer for it, but it's something that needs to be considered as part of how these technologies change the way we do things within the health care sector.
For me, as someone who used to spend a lot of time applying for research grants—not in nanotechnology but in other areas—I think we need larger grant amounts and targeted funding more often than we have currently so that we can actually focus our efforts on a given area, whether it's nanotechnology, or genomics, or whatever.